Pharmacovigilance and Reporting Adverse Drug Reactions

被引：0
|
作者：
Isa, N. M. [1 ]
机构：
[1] Univ Kebangsaan Malaysia, Med Ctr, Dept Pharmacol, Fac Med,Pharmacoepidemiol & Drug Safety Unit, Kuala Lumpur 56000, Malaysia
来源：
MEDICINE AND HEALTH-KUALA LUMPUR | 2014年 / 9卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：92 / 102
页数：11
相关论文
共 50 条
  • [1] Pharmacovigilance and the reporting of adverse drug reactions
    Terblanche, Antoinette
    [J]. SA PHARMACEUTICAL JOURNAL, 2018, 85 (06) : 65 - 68
  • [2] Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
    Kalaiselvan, Vivekanandan
    Prasad, Thota
    Bisht, Akanksha
    Singh, Surinder
    Singh, Gyanendra Nath
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2014, 140 : 563 - 564
  • [3] Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
    Tandon, Vishal R.
    Mahajan, Vivek
    Khajuria, Vijay
    Gillani, Zahid
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (01) : 65 - 71
  • [4] Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system
    Rebelo Gomes, Eva
    Ribeiro-Vaz, Ines
    Santos, Cristina Costa
    Herdeiro, Maria Teresa
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 915 - 922
  • [5] Patient Reporting of Adverse Drug Reactions; Experience of Toulouse Regional Pharmacovigilance Center
    Chebane, L.
    Abadie, D.
    Bagheri, H.
    Durrieu, G.
    Montastruc, J. L.
    [J]. DRUG SAFETY, 2012, 35 (10) : 942 - 942
  • [6] SPONTANEOUS REPORTING AND ANALYSIS OF ADVERSE DRUG REACTIONS IN A TEACHING HOSPITAL: A PHARMACOVIGILANCE STUDY
    Babu, A. V. Kishore
    Rao, A. Srinivasa
    [J]. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 222 - 231
  • [7] Patient reporting of adverse drug reactions: experience of Toulouse regional pharmacovigilance center
    Abadie, D.
    Bagheri, H.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 37 - 37
  • [8] Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?
    Ibrahim, Dina Mohamed
    Shawki, May Ahmed
    Solayman, Mohamed Hassan
    Sabri, Nagwa Ali
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [9] patients' perspective on pharmacovigilance and adverse drug reactions reporting in Lithuania: Qualitative study
    Valinciute-Jankauskiene, Agne
    Kubiliene, Loreta
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 511 - 511
  • [10] Advocacy for Dedicated Pharmacovigilance Systems in Oncology to Promote the Reporting of Adverse Drug Reactions
    Quillet, P.
    Heath, D.
    Bourneau-Martin, D.
    Devys, C.
    Laine, P.
    [J]. DRUG SAFETY, 2013, 36 (09) : 803 - 803
12345